EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Annals of OncologyPublished 1 December 2003Open access
Michel P. Coleman, Gemma Gatta, A. Verdecchia, Jacques Estève, Milena Sant, Hans H. Storm
Citations476
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The mission of cancer registries should be reconsidered, and the priority shifted from classical descriptive epidemiology and geo-graphical pathology toward more analytical monitoring of progress against cancer, including the probability of survival and cure, the burden of cancer prevalence, andThe late effects of therapy.
Abstract
No abstract available
Keywords
Medicine
Cancer Incidence in Five Continents
8,539 Citations1970Richard Doll, C. S. Muir +1 more
Statistical Methods in Cancer Research
6,727 Citations1980N. E. Breslow
Journal of Chronic DiseasesMaximum utilization of the life table method in analyzing survival
2,912 Citations1958Sidney J. Cutler, Fred Ederer
Acceptance of survival as a criterion for measuring the effectiveness of cancer therapy is attested to by the very large number of papers published every year reporting on the survival experience of cancer patients.
Annals of OncologyEUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
1,012 Citations2003Milena Sant, Tiiu Aareleid +16 more
Survival for all tumours combined was better in young than old patients, and better in women than men, and the affluence of countries influenced overall cancer survival through the availability of adequate diagnostic and treatment procedures, and screening programmes.
European Journal of CancerEstimates of cancer incidence and mortality in Europe in 1995
688 Citations2002Freddie Bray, Risto Sankila +2 more
Cancer incidence and mortality estimates for 1995 are presented for the 38 countries in the four United Nations-defined areas of Europe, using World Health Organization mortality data and published estimates of incidence from national cancer registries to demonstrate the very substantial burden of cancer in Europe, and the scope for prevention.
The LancetUK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years
648 Citations2000Richárd Pető, Jillian Boreham +3 more
The LancetLong-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
555 Citations2002Hermann Brenner
This work aimed to assess achievements in cancer patients' survival by an alternative method of survival analysis, known as period analysis, which provides more up-to-date estimates of long-term survival rates than do conventional methods.
BiometricsCancer Survival Corrected for Heterogeneity in Patient Withdrawal
452 Citations1982Timo Hakulinen
A method based on the concept of an 'expected life table' is proposed for removal of the bias and it is suggested that the practical performance of the proposed method is better than that of other alternatives, even when the relative survival rates in the subgroups are not equal.
JAMAAre Increasing 5-Year Survival Rates Evidence of Success Against Cancer?
447 Citations2000H. Gilbert Welch
Although 5-year survival is a valid measure for comparing cancer therapies in a randomized trial, the analysis shows that changes in 5- year survival over time bear little relationship to changes in cancer mortality and appear primarily related to changing patterns of diagnosis.
BMJEffect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality
389 Citations2000R G Blanks
Assessment of the impact of the NHS breast screening programme on mortality from breast cancer in women aged 55-69 years over the period 1990-8 found both screening and other factors, including improvements in treatment, had resulted in substantial reductions in mortality.
International Journal of CancerStage at diagnosis is a key explanation of differences in breast cancer survival across Europe
311 Citations2003Milena Sant, Claudia Allemani +11 more
Overall 5‐year relative survival was highest in the French group of Bas‐Rhin, Côte d'Or, Hérault and Isère (86%), and lowest in Estonia (66%), and these geographic groups were characterised by the highest and lowest percentages of women with early stage disease.
Biomedicine & PharmacotherapyOxford textbook of oncology
299 Citations1996Michael Peckham, Herbert M. Pinedo +1 more
GutUnderstanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study
274 Citations2000Gemma Gatta, R Capocaccia +12 more
There was a twofold range in the risk of death from colorectal cancer even after adjustment for surgery and disease stage, and there were wide variations in diagnostic and surgical practices.
JNCI Journal of the National Cancer InstituteCancer Surveillance Series: Interpreting Trends in Prostate Cancer Part II: Cause of Death Misclassification and the Recent Rise and Fall in Prostate Cancer Mortality
261 Citations1999Eric J. Feuer, Ray M. Merrill +1 more
The rise and fall in prostate cancer mortality observed since the introduction of PSA testing in the general population are consistent with a hypothesis that a fixed percent of the rising and falling pool of recently diagnosed patients who die of other causes may be mislabeled as dying of prostate cancer.
CancerChildhood cancer survival in Europe and the United States
259 Citations2002Gemma Gatta, Riccardo Capocaccia +3 more
Whether transatlantic differences in survival also are present in childhood cancers in the United States is investigated.
PubMedSocioeconomic differences in cancer survival: a review of the evidence.
244 Citations1997Manolis Kogevinas, Miquel Porta
The pattern of the social differences in survival did not vary consistently by sex, country, or source of the study population and did not depend on the socioeconomic indicator used.
BMJAudit of public education campaign to encourage earlier detection of malignant melanoma.
205 Citations1992R.M. MACKIE, David Hole
The public education campaign to encourage earlier referral and treatment of primary cutaneous malignant melanoma and thus reduce mortality related to melanoma succeeded in reducing the absolute number of thick tumours and melanoma related mortality in women.
Statistics in MedicineMixture models for cancer survival analysis: application to population-based data with covariates
197 Citations1999Roberta De Angelis, Riccardo Capocaccia +3 more
An application of a parametric mixture model to relative survival rates of colon cancer patients from the Finnish population-based cancer registry is proposed, including major survival determinants as explicative covariates and support the hypothesis that observed survival trends are really due to a real prognostic gain for more recently diagnosed patients.
Annals of OncologyCancer prevalence in European registry areas
195 Citations2002Andrea Micheli, E. Mugno +7 more
The largest project on prevalence conducted to date, EUROPREVAL has provided complete and accurate estimates of cancer prevalence in Europe, constituting essential information for cancer management and should therefore be prioritised.
BMJChanges in incidence of and mortality from breast cancer in England and Wales since introduction of screening
179 Citations1995Mike Quinn, Elizabeth Allen
Since the introduction of screening there have been pronounced increases in recorded incidence in the screened age group, including a steep decrease in mortality in 55-69 year olds which began three years after screening started.
Archives of Internal MedicineCancer Survival in Kentucky and Health Insurance Coverage
162 Citations2003Kathleen McDavid, T. C. Tucker +2 more
Findings confirm purported disparities in cancer care and point toward the need to make quality care accessible to all segments of the population.
European Journal of CancerCancer survival increases in Europe, but international differences remain wide
160 Citations2001Milena Sant, Riccardo Capocaccia +11 more
For potentially curable malignancies such as Hodgkin's disease, large bowel, breast and testicular cancers, there were substantial increases in survival, suggesting an earlier diagnosis and more effective treatment.
PubMedAn overview of cancer survival in developing countries.
153 Citations1998Rengaswamy Sankaranarayanan, Black Rj +2 more
Four types of approaches in the development of cancer control measures are recommended: population-based cancer registries for many developing countries high-resolution studies community-based intervention trials and balanced investment in theDevelopment of adequate diagnostic and treatment facilities.
European Journal of CancerThe prognostic role of gender in survival of adult cancer patients
147 Citations1998Andrea Micheli, Angela B. Mariotto +3 more
The results were consistent with the general observation that in the industrialised countries women tend to survive longer than men, and suggest that women may be intrinsically more robust than men in coping with cancer.
CancerToward a comparison of survival in American and European cancer patients
147 Citations2000Gemma Gatta, Riccardo Capocaccia +7 more
Only recently have extensive population‐based cancer survival data become available in Europe, providing an opportunity to compare survival in Europe and the United States.
Annals of OncologyEuropean health systems and cancer care
146 Citations2003Andrea Micheli, J.W.W. Coebergh +30 more
European Journal of CancerVariation in survival of patients with lung cancer in Europe, 1985–1989
142 Citations1998M.L.G. Janssen‐Heijnen, Gemma Gatta +3 more
A fairly large variation in lung cancer relative survival rates existed between European countries, with the most likely explanation for the differences is the variation in access to specialised care.
BMJIncidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status
113 Citations1996R.M. MacKie, David Hole
Although the incidence of cutaneous malignant melanoma is higher among more affluent people, the prognosis is better in this group than for less affluent individuals, and five year disease free survival prospects are better for affluent people.
European Journal of CancerComparison of stomach cancer incidence and survival in four continents
113 Citations2003A. Verdecchia, Angela B. Mariotto +3 more
The large survival differences between the four areas were almost totally due to the different case mixes of the stomach cancer patients and the importance of stage indicates that diagnostic delay may be a major clinical factor affecting survival.
European Journal of CancerVariation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours
110 Citations1998Franco Berrino, Gemma Gatta
Geographical differences in survival between Western Europe countries were largely due to a difference in case mix of anatomical sub-sites, however, after correcting for different sub-site distribution, differences persisted between Eastern and Western European countries.
Annals of OncologyMeasuring cancer prevalence in Europe: the EUROPREVAL Project
103 Citations2002Riccardo Capocaccia, Marc Colonna +5 more
A method is presented for the calculation of prevalence of all cancers combined in the populations covered by the 45 cancer registries participating in EUROPREVAL, with the highest values in Sweden and the lowest in Eastern Europe.
Annals of OncologyCancer prevalence in the UK: results from the EUROPREVAL study
92 Citations2003D Forman, Diane Stockton +5 more
The estimates of prevalence presented here comprise: recently diagnosed patients in need of treatment and monitoring; long-term survivors; and patients in the terminal phase who are dying from the cancer.
International Journal of CancerThe cure for colon cancer: Results from the EUROCARE study
91 Citations1998Arduino Verdecchia, Roberta De Angelis +5 more
The results are consistent with the hypothesis that a real improvement in colon cancer survival took place in Europe during the years 1978–1985 and suggest that the well‐known decrease of relative survival with age at diagnosis could be mostly due to a decreasing efficacy of early diagnosis for patients under 60 years old and to less effective therapies for older patients.
Annals of OncologyThe EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis
86 Citations2003Riccardo Capocaccia, Gemma Gatta +5 more
Comparison of quality indicators for the EUR OCARE-3 database with earlier EUROCARE databases indicates that data quality and standardisation have improved, and overall European survival for each cancer site and for all cancers combined were calculated combining country-specific survival figures.
European Journal of CancerImproved survival of patients with rectal cancer since 1980: a population-based study
80 Citations2003Hendrik Martijn, Adri C. Voogd +4 more
It is very likely that the continuing increase in population-based survival among patients aged <75 years results from the shift from postoperative to preoperative radiotherapy, the development of the total mesorectal excision technique and the related tendency to subspecialisation of surgeons in colorectAL cancer surgery.
Journal of Chronic DiseasesEstimating the expectation of life in cancer survival studies with incomplete follow-up information
78 Citations1977Matti Hakama, Timo Hakulinen
Techniques for estimating the expectation of life in cancer survival studies with incomplete follow-up information on the patients are described, based upon both the estimated patient survival, and the life tables for the general population.
International Journal of CancerDifferences in stage and therapy for breast cancer across Europe
71 Citations2001Milena Sant, Eurocare Working Group
Wide differences in breast cancer care across Europe in the early 1990s indicate a need for continual monitoring of past treatments to help ensure application of the most effective protocols.
Acta OncologicaRelative Survival of Cancer Patients: A Comparison between Denmark and the other Nordic Countries
71 Citations1998Anders Engeland, Tor Haldorsen +5 more
It appears that Danish cancer patients are diagnosed at a later stage of disease than patients in the other Nordic countries, and have the lowest proportion of localized tumours.
British Journal of CancerCompleteness of cancer registration: a new method for routine use
70 Citations2000Jared Bullard, Michel P. Coleman +4 more
A new method of estimating the completeness of cancer registration is reported, in which the proportions of unregistered patients are derived from the time distributions of three probabilities, each of which can be directly estimated from the registry’s own data.
British journal of surgeryBenefit of operative mortality reduction on colorectal cancer survival
70 Citations2002Emmanuel Mitry, A-M Bouvier +2 more
European Journal of CancerRelative survival in elderly cancer patients in Europe
63 Citations1998Marina Vercelli, Alberto Quaglia +4 more
The results are in agreement with other population-based studies, confirming a worse prognosis for the elderly in both sexes and the lack of equality in providing adequate treatment to elderly cancer patients should be addressed as a matter of urgency by health-care providers.
BMJRedesigning cancer care
59 Citations2002Rachel Kerr
The cancer services collaborative is using improvement methods to reduce delays and improve the service for patients, and nine cancer networks using these methods have cut waiting times and improved patients' experiences of care.
Annals of OncologyLife expectancy and cancer survival in the EUROCARE-3 cancer registry areas
56 Citations2003Andrea Micheli, Paolo Baili +4 more
It is found that within-country LE variation was large in some countries (particularly the UK).
European UrologyRecent Trends in Prostate Cancer Incidence and Mortality in Southeast England
50 Citations2003Helen Evans
The aggregate effect of PSA testing and medical treatment of BPH is a stabilisation in the incidence level of localised cases in recent years, likely to be principally due to increased detection through increased use of prostate-specific antigen (PSA) testing followed by radical resections of the prostate.
The LancetTrends in breast cancer incidence, survival, and mortality
50 Citations2000Michel P. Coleman
European Journal of CancerChildhood cancer survival in Europe, 1978–1992
48 Citations2001J.W.W. Coebergh, R. Capocaccia +3 more
Clinical MedicineConfidentiality and the public interest in medical research – will we ever get it right?
47 Citations2003Michel P. Coleman, Barry Evans +1 more
The Government should survey public opinion, inform NHS patients better, initiate wide public debate, and legislate to protect both citizens' rights and medical research that is demonstrably in the public interest.
European Journal of CancerChildhood cancer survival in Europe
45 Citations2001Benedetto Terracini, J.W.W. Coebergh +5 more
A regression analysis of incidence, mortality and survival rates during 1978-1989 over the whole EUROCARE database strongly indicates that the prognostic improvements over time are real and cannot be attributed to changes in diagnostic procedures.
European UrologyProstate Cancer Screening in Tyrol, Austria: Experience and Results
43 Citations1999Wolfgang Horninger, Andreas Reissigl +5 more
This article summarizes the experience and results of different prostate carcinoma screening projects using total prostate-specific antigen (PSA) and percent free PSA as the initial test and investigates the correlation between preoperative predictors and pathologic features in radical prostatectomy specimens.
European Journal of CancerSubstantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987
41 Citations1996Gemma Gatta, Milena Sant +2 more
The proportion of surgically resected patients correlated positively with the 5-year relative survival probability reported by the recently published EUROCARE study, this may be part of the explanation for the major differences in survival for these cancers among different European populations.
Tumori JournalInterpreting Survival Differences and Trends
39 Citations1997Franco Berrino, Andrea Micheli +2 more
To help disentangle the effects of early diagnosis and better treatment, several statistical approaches are being developed: multivariate analysis on relative survival data, new modeling analysis to separately estimate the proportion of cured patients and the length of survival for those patients destined to die, and the standardized collection of information on stage at diagnosis and staging procedures.
European Journal of CancerSurvival of adult patients with cancer of soft tissues or bone in Europe
37 Citations1998Hans H. Storm
The variation in relative survival for bone cancer between countries was substantial, with the lowest rates seen in the Eastern countries, and Denmark had the highest rates of the Nordic countries, similar to those of Scotland.
European Respiratory JournalDo morphology and stage explain the inferior lung cancer survival in Denmark?
35 Citations1999Hans H. Storm, Paul W. Dickman +3 more
A poor survival rate for small cell anaplastic lung carcinoma compared with all other morphologies was confirmed, and the main factor in the lower survival rate in Denmark is unfavourable stage distribution.
British Journal of CancerInfluence of stage at diagnosis on survival differences for rectal cancer in three European populations
32 Citations1999Élisabeth Monnet, Jean Faivre +2 more
Diagnostic conditions appear to be the main determinant of the survival inequalities found in those three European populations, mainly due to stage at diagnosis.
Annals of OncologyElectronic availability of EUROCARE-3 data: a tool for further analysis
32 Citations2003P. Roazzi, Riccardo Capocaccia +2 more
This paper will report a descriptive analysis of relative survival patterns for all cancers combined, by age, sex and country, as an example of how to use this CD-ROM.
European Journal of CancerVariation in survival for adults with Nasopharyngeal cancer in Europe, 1978–1989
29 Citations1998Jiong Li, Franco Berrino +1 more
During the period 1978-1989, 2,054 new patients with nasopharyngeal carcinoma (NPC) were registered in the EUROCARE study, which, during 1985-1989 involved 45 population-based cancer registries in 17 countries.
European Journal of Public HealthCancer control in Europe: A proposed set of European Cancer Health Indicators
27 Citations2003Andrea Micheli
There is now greater information on the increasing numbers of patients living with a previous cancer diagnosis (prevalence) in European populations, which assists efforts to estimate future demand for medical services.
BMJEffect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database
21 Citations2000A. Stotter
The effect of improved ascertainment on incidence and survival of breast cancer patients at Glenfield Hospital in 1998 was estimated by investigating three main issues.
Public HealthCancer survival rates and GDP expenditure on health a comparison of England and Wales and the USA, Denmark, Netherlands, Finland, France, Germany, Italy, Spain and Switzerland in the 1990s
20 Citations2000B. Evans
Higher GDP health expenditure and longer survival rates for each gender were significantly correlated indicating a possible association between fiscal input and clinical outcomes, which poses problems for the development of effective public health.
International Symposium on End Results of Cancer Therapy
20 Citations2016Sidney J. Culture
Journal of Medical ScreeningReliability of Underlying Incidence Rates for Estimating the Effect and Efficiency of Screening for Breast Cancer
19 Citations1996P Prior, C B J Woodman +2 more
An age-period model was constructed to predict what the incidence of breast cancer might now have been if the screening programme had not been introduced and the use of a universal rate, applied across all calendar years and age groups, would seem to be inappropriate when setting targets.
Tumori JournalThe Itacare Study
17 Citations1997Milena Sant, Gemma Gatta +5 more
Overall mortality decreased during the period, more markedly in the north and among women, and the highest mortality was among women of the Ragusa CR (Sicily) and men in northern CRs.
The LancetEUROCARE-2: relevance for assessment of quality of cancer services?
14 Citations2000Les Irwig, Bruce K. Armstrong
British Journal of CancerAre differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?
14 Citations2001C B J Woodman, Alan C. Gibbs +3 more
This study uses a comparison of cancer survival rates across 17 European countries, based on data collected by national and regional cancer registries, as an example to illustrate the methodological difficulties which may arise during such international comparisons.
BMJStudy demonstrates link between cancer survival and wealth
10 Citations1999Peter Anderson
It is suggested that over 12700 deaths from cancer could be avoided every year if all patients shared the survival rates of the most affluent patients.
BMJComparing survival rates between different registries can be difficult
8 Citations2000David Robinson, Janine Bell +1 more
The paper by Stotter et al is an important reminder of the need for caution when comparing incidence and survival rates between different populations.